
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 21, 2023, titled "Glenmark Pharma Announces Proposed Divestment of Majority Stake in GlenmarkLife Sciences".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 21, 2023, titled "Glenmark Pharma Announces Proposed Divestment of Majority Stake in GlenmarkLife Sciences".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals